IBDEI0JG ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9040,1,3,0)
 ;;=3^DM Type 2 w/ Mild NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9040,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,9040,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,9041,0)
 ;;=E11.319^^41^473^24
 ;;^UTILITY(U,$J,358.3,9041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9041,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9041,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,9041,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,9042,0)
 ;;=E11.311^^41^473^25
 ;;^UTILITY(U,$J,358.3,9042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9042,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9042,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,9042,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,9043,0)
 ;;=E10.9^^41^473^13
 ;;^UTILITY(U,$J,358.3,9043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9043,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,9043,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,9043,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,9044,0)
 ;;=E10.311^^41^473^11
 ;;^UTILITY(U,$J,358.3,9044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9044,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9044,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,9044,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,9045,0)
 ;;=E10.319^^41^473^12
 ;;^UTILITY(U,$J,358.3,9045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9045,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9045,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,9045,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,9046,0)
 ;;=E10.36^^41^473^1
 ;;^UTILITY(U,$J,358.3,9046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9046,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,9046,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,9046,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,9047,0)
 ;;=E10.39^^41^473^2
 ;;^UTILITY(U,$J,358.3,9047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9047,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,9047,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,9047,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,9048,0)
 ;;=E10.321^^41^473^3
 ;;^UTILITY(U,$J,358.3,9048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9048,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9048,1,4,0)
 ;;=4^E10.321
 ;;^UTILITY(U,$J,358.3,9048,2)
 ;;=^5002594
 ;;^UTILITY(U,$J,358.3,9049,0)
 ;;=E10.329^^41^473^4
 ;;^UTILITY(U,$J,358.3,9049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9049,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9049,1,4,0)
 ;;=4^E10.329
 ;;^UTILITY(U,$J,358.3,9049,2)
 ;;=^5002595
 ;;^UTILITY(U,$J,358.3,9050,0)
 ;;=E10.331^^41^473^5
 ;;^UTILITY(U,$J,358.3,9050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9050,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9050,1,4,0)
 ;;=4^E10.331
 ;;^UTILITY(U,$J,358.3,9050,2)
 ;;=^5002596
 ;;^UTILITY(U,$J,358.3,9051,0)
 ;;=E10.339^^41^473^6
 ;;^UTILITY(U,$J,358.3,9051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9051,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9051,1,4,0)
 ;;=4^E10.339
 ;;^UTILITY(U,$J,358.3,9051,2)
 ;;=^5002597
 ;;^UTILITY(U,$J,358.3,9052,0)
 ;;=E10.341^^41^473^9
 ;;^UTILITY(U,$J,358.3,9052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9052,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
